206 related articles for article (PubMed ID: 10216095)
1. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
2. Fibrate-modulated expression of fibrinogen, plasminogen activator inhibitor-1 and apolipoprotein A-I in cultured cynomolgus monkey hepatocytes -- role of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Princen HM; Kooistra T
Thromb Haemost; 1998 Dec; 80(6):942-8. PubMed ID: 9869165
[TBL] [Abstract][Full Text] [Related]
3. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression.
Post SM; Duez H; Gervois PP; Staels B; Kuipers F; Princen HM
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1840-5. PubMed ID: 11701475
[TBL] [Abstract][Full Text] [Related]
4. Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response element.
Gervois P; Chopin-Delannoy S; Fadel A; Dubois G; Kosykh V; Fruchart JC; Najïb J; Laudet V; Staels B
Mol Endocrinol; 1999 Mar; 13(3):400-9. PubMed ID: 10076997
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor alpha-dependent pathway.
Edgar AD; Tomkiewicz C; Costet P; Legendre C; Aggerbeck M; Bouguet J; Staels B; Guyomard C; Pineau T; Barouki R
Toxicol Lett; 1998 Sep; 98(1-2):13-23. PubMed ID: 9776557
[TBL] [Abstract][Full Text] [Related]
6. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
Schoonjans K; Peinado-Onsurbe J; Lefebvre AM; Heyman RA; Briggs M; Deeb S; Staels B; Auwerx J
EMBO J; 1996 Oct; 15(19):5336-48. PubMed ID: 8895578
[TBL] [Abstract][Full Text] [Related]
8. Fibrate induction of the adrenoleukodystrophy-related gene (ABCD2): promoter analysis and role of the peroxisome proliferator-activated receptor PPARalpha.
Fourcade S; Savary S; Albet S; Gauthé D; Gondcaille C; Pineau T; Bellenger J; Bentejac M; Holzinger A; Berger J; Bugaut M
Eur J Biochem; 2001 Jun; 268(12):3490-500. PubMed ID: 11422379
[TBL] [Abstract][Full Text] [Related]
9. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.
Kok T; Bloks VW; Wolters H; Havinga R; Jansen PL; Staels B; Kuipers F
Biochem J; 2003 Feb; 369(Pt 3):539-47. PubMed ID: 12381268
[TBL] [Abstract][Full Text] [Related]
11. Effects of peroxisome proliferator-activated receptor alpha activation on pathways contributing to cholesterol homeostasis in rat hepatocytes.
Le Jossic-Corcos C; Duclos S; Ramirez LC; Zaghini I; Chevillard G; Martin P; Pineau T; Bournot P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):49-58. PubMed ID: 15238219
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
[TBL] [Abstract][Full Text] [Related]
13. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators.
Martin G; Schoonjans K; Lefebvre AM; Staels B; Auwerx J
J Biol Chem; 1997 Nov; 272(45):28210-7. PubMed ID: 9353271
[TBL] [Abstract][Full Text] [Related]
14. Differences in the formation of PPARalpha-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration.
Rodríguez C; Noé V; Cabrero A; Ciudad CJ; Laguna JC
Mol Pharmacol; 2000 Jul; 58(1):185-93. PubMed ID: 10860941
[TBL] [Abstract][Full Text] [Related]
15. Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells.
Clavey V; Copin C; Mariotte MC; Baugé E; Chinetti G; Fruchart J; Fruchart JC; Dallongeville J; Staels B
Cell Physiol Biochem; 1999; 9(3):139-49. PubMed ID: 10494028
[TBL] [Abstract][Full Text] [Related]
16. Evidence against the peroxisome proliferator-activated receptor alpha (PPARalpha) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription.
Pan DA; Mater MK; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Lipid Res; 2000 May; 41(5):742-51. PubMed ID: 10787435
[TBL] [Abstract][Full Text] [Related]
17. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
[TBL] [Abstract][Full Text] [Related]
18. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.
Berthou L; Duverger N; Emmanuel F; Langouët S; Auwerx J; Guillouzo A; Fruchart JC; Rubin E; Denèfle P; Staels B; Branellec D
J Clin Invest; 1996 Jun; 97(11):2408-16. PubMed ID: 8647932
[TBL] [Abstract][Full Text] [Related]
19. Comparative effect of fenofibrate on hepatic desaturases in wild-type and peroxisome proliferator-activated receptor alpha-deficient mice.
Guillou H; Martin P; Jan S; D'Andrea S; Roulet A; Catheline D; Rioux V; Pineau T; Legrand P
Lipids; 2002 Oct; 37(10):981-9. PubMed ID: 12530558
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism.
Luc G; Jacob N; Bouly M; Fruchart JC; Staels B; Giral P
J Cardiovasc Pharmacol; 2004 Mar; 43(3):452-3. PubMed ID: 15076230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
